Literature DB >> 20414959

Altered intestinal microbiota in irritable bowel syndrome.

K J Lee1, J Tack.   

Abstract

Recent studies have suggested that alterations in the composition of the intestinal microbiota may play an important role in irritable bowel syndrome (IBS) symptoms. However, an association between the composition of the intestinal microbiota and IBS symptoms has not been clearly demonstrated. In the current issue of the Journal, Tana et al. suggest that altered intestinal microbiota contributes to the symptoms of IBS through increased levels of organic acids. In fecal samples, IBS patients had significantly higher numbers of Veillonella and Lactobacillus than healthy controls. They also showed significantly higher levels of acetic acid and propionic acid. Furthermore, IBS patients with high acetic acid or propionic acid levels presented more severe symptoms, impaired quality of life and negative emotions. These results are in accordance with the concept that the gut microbiota influences the sensory, motor and immune system of the gut and interacts with higher brain centers. Small intestinal bacterial overgrowth observed in a subset of IBS patients describes quantitative changes in the small intestinal microbiota. Data on qualitative changes in the gut microbiota in IBS patients are lacking. Different members of gut bacteria may have different influence on gut function. The concepts identified here may lead to the development of novel therapeutic strategies for IBS using manipulation of the intestinal microbiota.

Entities:  

Mesh:

Year:  2010        PMID: 20414959     DOI: 10.1111/j.1365-2982.2010.01482.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  27 in total

Review 1.  Indole compounds may be promising medicines for ulcerative colitis.

Authors:  Shinya Sugimoto; Makoto Naganuma; Takanori Kanai
Journal:  J Gastroenterol       Date:  2016-05-09       Impact factor: 7.527

2.  The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor.

Authors:  Jeffrey D Galley; Zhongtang Yu; Purnima Kumar; Scot E Dowd; Mark Lyte; Michael T Bailey
Journal:  Gut Microbes       Date:  2014

Review 3.  The intestinal microbiota and chronic disorders of the gut.

Authors:  Andrew W DuPont; Herbert L DuPont
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-16       Impact factor: 46.802

Review 4.  Recent developments in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

6.  Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.

Authors:  Rafid Kasir; Salam Zakko; Philip Zakko; Michael Adler; Aaron Lee; Sachin Dhingra; Cecile Guttermuth
Journal:  Dig Dis Sci       Date:  2015-09-11       Impact factor: 3.199

7.  ZBP-89 regulates expression of tryptophan hydroxylase I and mucosal defense against Salmonella typhimurium in mice.

Authors:  Bryan E Essien; Helmut Grasberger; Rachael D Romain; David J Law; Natalia A Veniaminova; Milena Saqui-Salces; Mohamad El-Zaatari; Arthur Tessier; Michael M Hayes; Alexander C Yang; Juanita L Merchant
Journal:  Gastroenterology       Date:  2013-02-07       Impact factor: 22.682

Review 8.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

Review 9.  IBS and the role of otilonium bromide.

Authors:  Guy Boeckxstaens; Enrico S Corazziari; Fermín Mearin; Jan Tack
Journal:  Int J Colorectal Dis       Date:  2012-11-22       Impact factor: 2.571

Review 10.  Breath tests and irritable bowel syndrome.

Authors:  Satya Vati Rana; Aastha Malik
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.